|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.630 CAD | -4.12% |
|
-10.44% | +24.43% |
Business description: Cardiol Therapeutics Inc.
Number of employees: 18
Sales by Activity: Cardiol Therapeutics Inc.
| Fiscal Period: December | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Pharmaceuticals | 78.76K | - | - | - | - |
Geographical breakdown of sales: Cardiol Therapeutics Inc.
| Fiscal Period: December | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Canada | 78.76K | - | - | - | - |
Executive Committee: Cardiol Therapeutics Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Elsley
CEO | Chief Executive Officer | - | 2017-01-18 |
| Director of Finance/CFO | - | 2018-08-15 | |
Bernard Lim
COO | Chief Operating Officer | - | 2020-12-02 |
Andrew Hamer
CTO | Chief Tech/Sci/R&D Officer | 64 | 2021-03-28 |
John Geddes
PRN | Corporate Officer/Principal | - | 2021-12-31 |
Composition of the Board of Directors: Cardiol Therapeutics Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Peter Pekos
BRD | Director/Board Member | - | 2017-12-14 |
David Elsley
BRD | Director/Board Member | - | 2017-01-18 |
| Chairman | - | 2021-07-06 | |
| Director/Board Member | - | 2022-05-18 | |
Colin Stott
BRD | Director/Board Member | 59 | 2019-12-02 |
Jennifer Chao
BRD | Director/Board Member | 56 | 2022-03-14 |
Teri Loxam
BRD | Director/Board Member | 54 | 2022-05-18 |
Timothy Garnett
BRD | Director/Board Member | 65 | 2025-05-27 |
Company details: Cardiol Therapeutics Inc.
Cardiol Therapeutics, Inc.
2265 Upper Middle Road East
L6H 0G5, Oakville
+289 910 0850
http://www.cardiolrx.com
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.12% | -10.44% | -18.91% | +13.99% | 133M | |
| +0.77% | +6.75% | +0.80% | +14.57% | 48.95B | |
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | |
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | |
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | |
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | |
| -0.94% | +0.05% | - | - | 16.62B | |
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | |
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | |
| +0.61% | +4.45% | +4.51% | +10.35% | 13.56B | |
| Average | -0.39% | +4.17% | +49.12% | +93.46% | 25.33B | |
| Weighted average by Cap. | -0.07% | +6.91% | +71.97% | +122.81% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRDL Stock
- Company Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
